Delivery Order SPE2DB20D3103-SPE2DB23FN4Q7

Award Date 5/19/23
Potential Completion Date 5/22/23
Potential Value $45K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $21,066.51 Firm Fixed Price Delivery Order is for the supply of ELIQUIS 5 MG TABLET 60S, a cardiovascular drug. The contract has an ultimate completion date of May 16, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
This federal contract award, valued at $15,255.89, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a completion date of December 22, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
This federal contract award, valued at $5,760.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The award has an ultimate completion date of February 8, 2024 and a Firm Fixed Price pricing type. This contract is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $7,774.21, is for a delivery order to provide ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of March 7, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $17,911.39 Firm Fixed Price Delivery Order is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The award has an ultimate completion date of January 31, 2024 and was made on January 30, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $12,252.77 for the supply of ELIQUIS 5 MG TABLET 60S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 28, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued up to $999,999,999.00 and running through November...
This is a delivery order valued at $6,870.46 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of 4560969799 ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The award has an ultimate completion date of May 18, 2023 and uses a firm fixed price pricing type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA...
This federal contract award, valued at $11,096.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4562031384 - ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a completion date of September 5, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,479.30 firm fixed-price delivery order is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This single-award IDC serves...
This federal contract award, valued at $10,453.08, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FN4Q7
    Delivery Order

This federal contract award, valued at $45,235.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order contract for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a completion date of May 22, 2023.

The contract is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support the healthcare needs of the Department of Defense and other federal agencies. The contract is awarded through full and open competition, with no set-aside designation.

Generated 5/9/25, 10:20 AM